Resources

In the previous article you learned about taking 3 drugs to reduce the risk of heart disease. This study show you how you can do the same thing for free.

A new study has shown us that diabetic adults’ ability to work with numbers may affect their management of the disease and that, in turn, may help explain racial differences in diabetes control.

Diabetes can be dangerous — especially when the disease is not diagnosed in time. Scientists have identified new markers which enable an early diagnosis and prognosis of Type 1 diabetes.

Women with Type 2 diabetes have a 26 percent increased risk of developing atrial fibrillation, a potentially life-threatening irregular heartbeat, new findings suggest. The reason behind the gender difference isn’t clear, researchers say.

The AADE Education and Research Foundation funded a study of Medicare and commercial member claims which revealed that people with diabetes who received diabetes education have lower average health care costs than patients who do not participate in diabetes education.

  Review By: Pamela Grimberg, University of Florida College of Pharmacy Doctorial Candidate   Dave Joffe, BSPharm, CDE, FACA   This book, written by Andrew S. Rhinehart, is a great reference book for Type 1 or Type 2 diabetic patients who need insulin therapy to maintain good glycemic control. Dr. …

For men with Type 2 diabetes, the eosinophil (a cell type linked to allergic inflammation) cell count may be able to estimate the risk of diabetes-related kidney and heart disease in men. This comes from a recently published study in Japan.

The higher incidence of diabetes among African Americans when compared to whites may have more to do with living conditions than genetics, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

U.S. health officials said on Friday they suspect Merck & Co., Inc.’s blockbuster diabetes drug Januvia may be linked to serious cases of inflamed pancreas, but company officials disputed the connection.

There is no reason to test overweight or obese children for insulin resistance, according to an international committee of experts in pediatric endocrinology and diabetes.